Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-09-25

FDA Approved: QUINAPRIL — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Quinapril from Chartwell RX, LLC, authorizing a generic quinapril product under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quinapril (quinapril)

Snippet

SUPPL AP for QUINAPRIL (QUINAPRIL)